While the agency stressed that increased screening was most likely behind much of the increase, the health secretary, Robert F. Kennedy Jr., called it an “epidemic.”
Related Posts
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class…
Therapy Notes Are Accessible to Patients. Is That a Good Thing?
Health care systems have been putting therapists’ progress reports online, much to the surprise (and anger) of some patients.
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
A committee of independent advisers to the Food and Drug Administration voted unanimously on Monday that the benefits outweigh the…